Provided by Tiger Trade Technology Pte. Ltd.

CorMedix Inc.

7.01
-0.0200-0.28%
Volume:1.17M
Turnover:8.17M
Market Cap:552.31M
PE:3.40
High:7.13
Open:6.96
Low:6.89
Close:7.03
52wk High:17.43
52wk Low:5.60
Shares:78.79M
Float Shares:73.69M
Volume Ratio:0.76
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.06
EPS(LYR):-0.3046
ROE:75.08%
ROA:15.68%
PB:1.48
PE(LYR):-23.02

Loading ...

CorMedix's Growth Outlook Hinges on Trial Data, Prophylaxis Opportunity, RBC Says

MT Newswires Live
·
Feb 12

CorMedix Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Feb 11

CorMedix Authorizes Up to $75 Million Stock Buyback; Shares Rise

MT Newswires Live
·
Feb 02

CorMedix board authorizes share repurchase program of up to $75M

TIPRANKS
·
Feb 02

CorMedix Therapeutics Announces Share Repurchase Program

THOMSON REUTERS
·
Feb 02

CorMedix Hosts Analyst Day to Showcase Pipeline and Growth Drivers

Reuters
·
Jan 29

Is CorMedix (CRMD) A Potential Opportunity After Recent Share Price Volatility?

Simply Wall St.
·
Jan 25

CorMedix Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 23

CorMedix Inc : H.c. Wainwright Cuts Target Price to $13 From $18

THOMSON REUTERS
·
Jan 23

CorMedix price target lowered to $13 from $18 at H.C. Wainwright

TIPRANKS
·
Jan 23

CorMedix Inc. Director Janet Dillione Reports Disposal of Common Shares

Reuters
·
Jan 23

CorMedix Inc : RBC Cuts Target Price to $13 From $22

THOMSON REUTERS
·
Jan 21

CorMedix Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Michael David Seckler

Reuters
·
Jan 16

CorMedix (CRMD) Valuation After New Leadership Moves And 2026 Revenue Guidance

Simply Wall St.
·
Jan 13

Analysts Conflicted on These Healthcare Names: Cormedix (CRMD), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Jan 13

Stock Track | CorMedix Inc. Plummets 5.24% Intraday After Leerink Partners Slashes Target Price

Stock Track
·
Jan 12

CorMedix Inc : Leerink Partners Cuts Target Price to $15 From $21

THOMSON REUTERS
·
Jan 12

Stock Track | CorMedix Inc. Soars 5.46% Intraday as CEO Prepares for J.P. Morgan Healthcare Conference Presentation

Stock Track
·
Jan 09

CorMedix CEO to Present Corporate Overview at J.P. Morgan Healthcare Conference

Reuters
·
Jan 09

CorMedix Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 09